Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Rizzi

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Frontiers in Cardiovascular Medicine|June 27, 2022
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 PatientsMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug MonitoringPier Giorgio Cojutti, Sara Tedeschi, Milo Gatti, et al.
Vaccines|October 28, 2023
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and RecipientsMauro Viganò, Marta Beretta, Marta Lepore, et al.
Epidemiology and Infection|January 19, 2021
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluationSerena Venturelli, Simone Vasilij Benatti, Monica Casati, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
JAMA|March 30, 2007
Contemporary clinical profile and outcome of prosthetic valve endocarditisAndrew Wang, Eugene Athan, Paul A Pappas, et al.
European Journal of Preventive Cardiology|September 18, 2021
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19Mauro Gori, Arianna Ghirardi, Emilia D'Elia, et al.
Antimicrobial Resistance and Infection Control|December 21, 2021
Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19Simon Matoori, Daniel R Kuritzkes, Yonggeng Goh, et al.
Leukemia|May 25, 2021
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, et al.
Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Frontiers in Cardiovascular Medicine|June 27, 2022
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 PatientsMarina Marchetti, Patricia Gomez-Rosas, Laura Russo, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Population Pharmacokinetic and Pharmacodynamic Analysis of Dalbavancin for Long-Term Treatment of Subacute and/or Chronic Infectious Diseases: The Major Role of Therapeutic Drug MonitoringPier Giorgio Cojutti, Sara Tedeschi, Milo Gatti, et al.
Vaccines|October 28, 2023
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and RecipientsMauro Viganò, Marta Beretta, Marta Lepore, et al.
Epidemiology and Infection|January 19, 2021
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluationSerena Venturelli, Simone Vasilij Benatti, Monica Casati, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
JAMA|March 30, 2007
Contemporary clinical profile and outcome of prosthetic valve endocarditisAndrew Wang, Eugene Athan, Paul A Pappas, et al.
European Journal of Preventive Cardiology|September 18, 2021
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19Mauro Gori, Arianna Ghirardi, Emilia D'Elia, et al.
Antimicrobial Resistance and Infection Control|December 21, 2021
Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19Simon Matoori, Daniel R Kuritzkes, Yonggeng Goh, et al.
Leukemia|May 25, 2021
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, et al.
Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
Pageof 9